1. Home
  2. CLNN vs MSAI Comparison

CLNN vs MSAI Comparison

Compare CLNN & MSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLNN
  • MSAI
  • Stock Information
  • Founded
  • CLNN 2012
  • MSAI 1995
  • Country
  • CLNN United States
  • MSAI United States
  • Employees
  • CLNN N/A
  • MSAI N/A
  • Industry
  • CLNN Biotechnology: Pharmaceutical Preparations
  • MSAI
  • Sector
  • CLNN Health Care
  • MSAI
  • Exchange
  • CLNN Nasdaq
  • MSAI Nasdaq
  • Market Cap
  • CLNN 37.7M
  • MSAI 43.0M
  • IPO Year
  • CLNN N/A
  • MSAI N/A
  • Fundamental
  • Price
  • CLNN $4.37
  • MSAI $1.16
  • Analyst Decision
  • CLNN Strong Buy
  • MSAI Strong Buy
  • Analyst Count
  • CLNN 4
  • MSAI 2
  • Target Price
  • CLNN $55.25
  • MSAI $5.25
  • AVG Volume (30 Days)
  • CLNN 42.3K
  • MSAI 199.0K
  • Earning Date
  • CLNN 05-07-2025
  • MSAI 11-12-2024
  • Dividend Yield
  • CLNN N/A
  • MSAI N/A
  • EPS Growth
  • CLNN N/A
  • MSAI N/A
  • EPS
  • CLNN N/A
  • MSAI N/A
  • Revenue
  • CLNN $421,000.00
  • MSAI $7,616,000.00
  • Revenue This Year
  • CLNN N/A
  • MSAI $127.29
  • Revenue Next Year
  • CLNN N/A
  • MSAI $229.75
  • P/E Ratio
  • CLNN N/A
  • MSAI N/A
  • Revenue Growth
  • CLNN N/A
  • MSAI 30.50
  • 52 Week Low
  • CLNN $3.82
  • MSAI $1.05
  • 52 Week High
  • CLNN $9.20
  • MSAI $3.49
  • Technical
  • Relative Strength Index (RSI)
  • CLNN 45.51
  • MSAI 39.23
  • Support Level
  • CLNN $4.25
  • MSAI $1.05
  • Resistance Level
  • CLNN $4.60
  • MSAI $1.23
  • Average True Range (ATR)
  • CLNN 0.32
  • MSAI 0.08
  • MACD
  • CLNN 0.01
  • MSAI 0.00
  • Stochastic Oscillator
  • CLNN 46.67
  • MSAI 33.33

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements).

About MSAI Infrared Cameras Holdings Inc.

MultiSensor AI Holdings Inc develops and sells a full-stack, AI-driven predictive maintenance solution. MultiSensor AI's SmartIR and associated software platforms, powered by AWS, leverage MSAI-built thermal imaging, visible imaging, acoustic imaging, vibration, and laser sensing devices for condition-based monitoring of critical mechanical and electrical assets and manufactured outputs. Its solutions are deployed by organizations to protect critical assets across a wide range of industries including distribution & logistics, manufacturing, utilities, and oil & gas. MSAI designs and manufactures digital thermal sensing solution platforms with edge and cloud-based software. The company generates the majority of its revenue from product sales.

Share on Social Networks: